ABSTRACT
The management of Graves’ hyperthyroidism has evolved in recent years chiefly due to a better understanding of the underlying molecular immunology and an ‘‘evidence-based’’ approach to clinical controversies. Since patients with Graves’ disease can present with signs and symptoms of orbitopathy, the ophthalmologist must recognize the signs and symptoms of, as well as the treatment options for, the associated thyrotoxicosis. In this chapter, an evidence-based algorithmic approach to the medical management of Graves’ hyperthyroidism is discussed.
